Study of severe breathing problems in people with lung scarring
Part of Lungs & breathing clinical trials.
This study follows patients with chronic lung scarring (fibrosing interstitial lung disease) who are in the intensive care unit for severe breathing failure. It aims to better understand their condition and care, which may help improve future treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are in the intensive care unit (ICU) because you have severe trouble breathing.
- You need a high amount of oxygen (more than 6 liters per minute), high-flow oxygen, or a breathing machine.
- You are 18 years old or older.
- You have been diagnosed with chronic interstitial lung disease (a long-term scarring condition of the lungs) before or during this hospital stay.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial looks at different types of lung scarring (called interstitial lung disease) to better understand the condition across all ages. It also includes family members of people with certain genetic mutations that affect the lungs.
This study is for people with a specific type of lung scarring (not IPF) to understand how the disease progresses. Researchers will collect detailed health information, imaging, and blood samples to learn more about the condition.
This study looks at how to find and treat fibrotic interstitial lung disease (a condition where lung tissue becomes scarred and stiff) as early as possible. It may help people with this type of lung disease get better care.
This study looks at how to better treat different types of lung scarring (fibrotic ILD) by focusing on each person's specific problems. It is for adults who are already being treated for a fibrotic ILD at one of two hospitals in Perth, Australia.
This study looks at people with interstitial lung diseases (lung scarring) who need care in the respiratory intensive care unit. It aims to understand their condition better.
This study collects health information over time from people with newly diagnosed idiopathic pulmonary fibrosis (IPF) or other lung scarring diseases that are getting worse. It’s meant to better understand disease patterns and outcomes, which may help doctors plan future care.
Hear when a new Fibrosing Interstitial Lung Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.